Since 2013, we have helped hundreds of entrepreneurs turn an idea into a business, and we are very proud of their many achievements. Here are some of our Accelerate Cambridge ventures that have been most successful in securing funds from investors.
Venture | Founded in | Funds raised | Employees | Industry | |
---|---|---|---|---|---|
bit.bio bit.bio is a synthetic biology company providing human cells for research, drug discovery and cell therapy. View venture |
2016 | £124m | 101-250 | Healthcare, pharma, biotech |
|
Healx Healx is a social enterprise passionate about finding new therapeutic solutions to cure patients with rare diseases. View venture |
2014 | £66.4m | 51-100 | Healthcare, pharma, biotech |
|
Speechmatics Speechmatics provides cloud-based speech recognition services that convert speech-to-text. View venture |
2006 | £60.1m | 101-250 | Technology |
|
Nuclera Nuclera is a US and UK-based biotechnology company driven by the mission to better human health by making proteins accessible. View venture |
2013 | £52.3m | 101-250 | Healthcare, pharma, biotech |
|
VocalIQ VocalIQ was formed in March 2011 to exploit technology developed by the Spoken Dialogue Systems Group at University of Cambridge, UK. View venture |
2011 | £49.5m | 1-10 | Computing, data, software |
|
Cytora Cytora is the configurable platform that enables commercial insurers to create digital workflows by digitising, evaluating and routing risks. View venture |
2014 | £31.6m | 11-50 | Risk management |
|
PostEra PostEra is the first company to algorithmically complete the ‘design-make-test’ cycle of drug discovery. View venture |
2019 | £20.8m | 11-50 | Healthcare, pharma, biotech |
|
Better Origin Better Origin sets out to transform food waste into sustainable products with the help of insects. View venture |
2015 | £19.2m | 11-50 | ESG, climate action |
|
Hummingbird Technologies Hummingbird Technologies is an artificial intelligence SaaS platform that provides actionable intelligence to farmers and agri-businesses at key decision-making times in the growing season. View venture |
2015 | £16.5m | 11-50 | Engineering |
|
PharmEnable PharmEnable explores new areas of chemical space that no one else is currently searching to enable the development of vital new medicines. View venture |
2016 | £12.2m | 1-10 | Healthcare, pharma, biotech |
|
Dogtooth Technologies Dogtooth Technologies is a Cambridge-based technology start-up that sells smart robots for harvesting soft fruits such as strawberries and raspberries. View venture |
2014 | £11.8m | 11-50 | Agritech |
|
Sano Genetics Sano’s patient finding and engagement services enable researchers to deliver precision medicine clinical trials at increased speed and lower cost. View venture |
2017 | £11.8m | 60 | Healthcare, pharma, biotech |
|
FA-Bio FA-Bio provides game-changing bio-products for agriculture that can replace chemical inputs. View venture |
2015 | £9.5m | 1-10 | Agriculture |
|
Charco Neurotech Charco Neurotech developed CUE1, a focused vibrotactile stimulation device for people with Parkinson’s. View venture |
2019 | £8.7m | 11-50 | Healthcare, pharma, biotech |
|
KisanHub-Arjun Technology Ventures KisanHub Agri-Food Supply Chain software helps producer groups to transform their supply chain and improve margins with greater visibility and data driven insights. View venture |
2014 | £7.3m | 11-50 | Agriculture |
|
Cambridge Cancer Genomics Cambridge Cancer Genomics developed precision oncology solutions to transform the way cancer patients are treated. View venture |
2016 | £7.2m | 11-50 | Healthcare, pharma, biotech |
|
MediaGamma/Nozzle ai MediaGamma is transforming the way digital media is valued, traded, and measured. View venture |
2014 | £5.8m | 11-50 | Arts, entertainment, media |
|
Antiverse Antiverse is developing a revolutionary technology to predict antibody drug hits in a single day rather than in months through the traditional methods. View venture |
2017 | £5.3m | 11-50 | Pharmaceutical |
|
Spotta Spotta intends to be the world leader in smart pest detection. View venture |
2008 | £5.1m | 1-10 | Agriculture |
|
Prosoma Prosoma is developing a comprehensive digital therapeutics programme, designed exclusively for cancer patients, including CBT, RBT, mindfulness, relaxation and breathing therapies. View venture |
2017 | £4.7m | 11-150 | Healthcare, pharma, biotech |
|
Polysolar Polysolar produces window glass that generates electricity. View venture |
2007 | £4.6m | 1-10 | Construction, engineering |
|
Edozo Edozo is an online community for commercial property professionals who wish to share high quality comparable evidence. View venture |
2016 | £4.6m | 11-50 | Real estate |
|
52North 52 North was launched to develop a transformative new medical device, NeutroCheck, presenting tangible efficiencies in patient care and healthcare resource, both financial and human. View venture |
2018 | £4.3m | 1-10 | Healthcare, pharma, biotech |
|
Satavia Satavia is an analytics and visualisation company that develops bespoke environmental awareness solutions for all segments of the aviation market. View venture |
2013 | £4.06m | 11-50 | Automotive, aerospace |
|
Animal Alternative Technologies Satavia is an analytics and visualisation company that develops bespoke environmental awareness solutions for all segments of the aviation market. View venture |
2020 | £3.9m | 1-10 | Manufacturing |
|
Spirea Spirea is developing the next generation of antibody drug conjugate cancer therapeutics. View venture |
2017 | £2.9m | 1-10 | Healthcare, pharma, biotech |
|
Syrona Health Syrona Health, a non-invasive, rapid diagnostic tool helps women better manage their own reproductive health. View venture |
2019 | £2.6m | 11-50 | Healthcare, pharma, biotech |
|
Kalium Health Kalium Health is developing the world’s first blood potassium test suitable for home use. View venture |
2018 | £2.5m | 11-50 | Healthcare, pharma, biotech |
|
Qureight Qureight combines technology and life sciences to generate new knowledge and transform the way we use clinical data. View venture |
2018 | £2.5m | 1-10 | Healthcare, pharma, biotech |
|
Upfront diagnostics LTD Upfront Diagnostics has discovered and validated novel blood biomarkers for the detection of stroke patients suffering from a large vessel occlusion. View venture |
2017 | £2.5m | 1-10 | Healthcare, pharma, biotech |